Adzenys XR-ODT 9.4 MG tablet UD 30S
Ended Awarded
- Contract number
- SPE2DB25FLJA9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,505
Award facts
- Contract value 100% obligated
- $1,504.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,504.87 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adzenys XR-ODT 9.4 mg tablets in unit-dose packaging (30 tablets). This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. Adzenys XR-ODT is an extended-release amphetamine-based medication used primarily in the treatment of attention-deficit/hyperactivity disorder (ADHD).
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including services to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capacity to fulfill federal medical procurement needs through open competition, combined with its extensive portfolio of pharmaceutical product deliveries, positions it as a critical vendor for DoD medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FLJA9?
SPE2DB25FLJA9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FLJA9 worth?
The government has obligated $1,505 on SPE2DB25FLJA9.
Is contract SPE2DB25FLJA9 an order under another contract?
Yes. SPE2DB25FLJA9 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLJA9 competed?
The extent of competition for SPE2DB25FLJA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award